Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute Kidney Injury Following In-Patient Lower Extremity Vascular Intervention: From the National Cardiovascular Data Registry.
Safley DM, Salisbury AC, Tsai TT, Secemsky EA, Kennedy KF, Rogers RK, Latif F, Shammas NW, Garcia L, Cavender MA, Rosenfield K, Prasad A, Spertus JA. Safley DM, et al. Among authors: secemsky ea. JACC Cardiovasc Interv. 2021 Feb 8;14(3):333-341. doi: 10.1016/j.jcin.2020.10.028. JACC Cardiovasc Interv. 2021. PMID: 33541543 Free PMC article.
Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention.
Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM 3rd, McNulty EJ, Scirica BM, Yeh RW. Waldo SW, et al. Among authors: secemsky ea. Circulation. 2014 Dec 23;130(25):2295-301. doi: 10.1161/CIRCULATIONAHA.114.011541. Epub 2014 Nov 12. Circulation. 2014. PMID: 25391519 Free PMC article.
Response to Letter Regarding Article, "Surgical Ineligibility and Mortality Among Patients With Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention".
Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM 3rd, McNulty EJ, Scirica BM, Yeh RW. Waldo SW, et al. Among authors: secemsky ea. Circulation. 2015 Sep 22;132(12):e156. doi: 10.1161/CIRCULATIONAHA.115.016777. Circulation. 2015. PMID: 26391303 No abstract available.
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L; DAPT Study Investigators. Yeh RW, et al. Among authors: secemsky ea. JAMA. 2016 Apr 26;315(16):1735-49. doi: 10.1001/jama.2016.3775. JAMA. 2016. PMID: 27022822 Free PMC article. Clinical Trial.
Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.
Secemsky EA, Kirtane A, Bangalore S, Jovin IS, Shah RM, Ferro EG, Wimmer NJ, Roe M, Dai D, Mauri L, Yeh RW. Secemsky EA, et al. JACC Cardiovasc Interv. 2016 Dec 12;9(23):2376-2386. doi: 10.1016/j.jcin.2016.09.020. Epub 2016 Nov 9. JACC Cardiovasc Interv. 2016. PMID: 27838271 Free article.
Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
Jovin IS, Shah RM, Patel DB, Rao SV, Baklanov DV, Moussa I, Kennedy KF, Secemsky EA, Yeh RW, Kontos MC, Vetrovec GW. Jovin IS, et al. Among authors: secemsky ea. JACC Cardiovasc Interv. 2017 Jun 12;10(11):1102-1111. doi: 10.1016/j.jcin.2017.03.021. Epub 2017 May 17. JACC Cardiovasc Interv. 2017. PMID: 28527778 Free article.
274 results